The FDA has approved a screening test for the breast cancer gene that women will soon be able to order without consulting a doctor. But some geneticists fear the new test will give people a false sense of security. We'll discuss screening methodology and a University of California study that compares the accuracy of genetic tests to mammograms for predicting breast cancer risk.
Dr. Laura Esserman, professor of surgery and radiology and director, Carol Franc Buck Breast Care Center at UCSF; principal investigator of the Wisdom Study
Carrie Feibel, health editor, KQED